标题
Nanocell targeting using engineered bispecific antibodies
作者
关键词
-
出版物
mAbs
Volume 7, Issue 1, Pages 53-65
出版商
Informa UK Limited
发表日期
2014-12-19
DOI
10.4161/19420862.2014.985952
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- An EGFR targeting nanoparticle self assembled from a thermoresponsive polymer
- (2014) Stephen Goodall et al. JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
- Drug delivery vehicles on a nano-engineering perspective
- (2014) Betiana Felice et al. Materials Science & Engineering C-Materials for Biological Applications
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Injectable nanomaterials for drug delivery: Carriers, targeting moieties, and therapeutics
- (2013) David M. Webster et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Antibodies to watch in 2013
- (2013) Janice M Reichert mAbs
- Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
- (2013) Lei Wang et al. PLoS One
- Targeted Liposome-Loaded Microbubbles for Cell-Specific Ultrasound-Triggered Drug Delivery
- (2013) Bart Geers et al. Small
- Toward aggregation-resistant antibodies by design
- (2013) Christine C. Lee et al. TRENDS IN BIOTECHNOLOGY
- A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications
- (2013) Hannah Byrne et al. TRENDS IN BIOTECHNOLOGY
- The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting
- (2013) Djordje Atanackovic et al. Human Vaccines & Immunotherapeutics
- Nanoparticles in drug delivery: Past, present and future
- (2012) P. Couvreur ADVANCED DRUG DELIVERY REVIEWS
- Advances in bispecific biotherapeutics for the treatment of cancer
- (2012) Chad May et al. BIOCHEMICAL PHARMACOLOGY
- The future of antibodies as cancer drugs
- (2012) Janice M. Reichert et al. DRUG DISCOVERY TODAY
- A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
- (2012) Stephanie D. Steichen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- RECRUIT-TandAbs®: harnessing the immune system to kill cancer cells
- (2012) Fionnuala McAleese et al. Future Oncology
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Dual targeting strategies with bispecific antibodies
- (2012) Roland Kontermann mAbs
- Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing
- (2012) S. Metz et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions
- (2012) J. M. Perchiacca et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Panitumumab (Vectibix): Fig 1.
- (2011) J.J. Gemmete et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains
- (2011) Jürgen Schanzer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mammalian cell protein expression for biopharmaceutical production
- (2011) Jianwei Zhu BIOTECHNOLOGY ADVANCES
- Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
- (2011) P. A. Moore et al. BLOOD
- Minicells: Versatile vectors for targeted drug or si/shRNA cancer therapy
- (2011) Jennifer A MacDiarmid et al. CURRENT OPINION IN BIOTECHNOLOGY
- Recent advances in the application of antibodies as therapeutics
- (2011) Roberta E Burden et al. Future Medicinal Chemistry
- Antibody-targeted nanoparticles for cancer therapy
- (2011) Francois Fay et al. Immunotherapy
- Therapeutic antibodies: Market considerations, disease targets and bioprocessing
- (2011) John G. Elvin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Efficient mAb production in CHO cells incorporating PEI-mediated transfection, mild hypothermia and the co-expression of XBP-1
- (2011) Joe Codamo et al. JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Drug Delivery Using Immunoconjugates
- (2011) Maria Valentina Pasquetto et al. JOURNAL OF IMMUNOTHERAPY
- Bio-inspired, bioengineered and biomimetic drug delivery carriers
- (2011) Jin-Wook Yoo et al. NATURE REVIEWS DRUG DISCOVERY
- A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies
- (2010) Martina L. Jones et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion
- (2010) Syd Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Bispecific antibodies for cancer therapy
- (2010) Patrick Chames et al. mAbs
- Structural and functional characterization of the trifunctional antibody catumaxomab
- (2010) Dirk Chelius et al. mAbs
- A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo
- (2010) Robert Mabry et al. mAbs
- Catumaxomab
- (2010) Rolf Linke et al. mAbs
- T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
- (2010) Ralf Lutterbuese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties
- (2010) G. Wozniak-Knopp et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Stability engineering of scFvs for the development of bispecific and multivalent antibodies
- (2010) Brian R. Miller et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Remodeling domain interfaces to enhance heterodimer formation
- (2010) Zhenping Zhu et al. PROTEIN SCIENCE
- Next generation immunotherapeutics—honing the magic bullet
- (2009) Carrie Enever et al. CURRENT OPINION IN BIOTECHNOLOGY
- A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activityin vivo
- (2009) Timothy E. Adams et al. GROWTH FACTORS
- An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies
- (2009) Matthias J. Feige et al. MOLECULAR CELL
- Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug
- (2009) Jennifer A MacDiarmid et al. NATURE BIOTECHNOLOGY
- Engineering of stable bispecific antibodies targeting IL-17A and IL-23
- (2009) Robert Mabry et al. PROTEIN ENGINEERING DESIGN & SELECTION
- When binding is enough: nonactivating antibody formats
- (2008) Aran F Labrijn et al. CURRENT OPINION IN IMMUNOLOGY
- Molecular engineering and design of therapeutic antibodies
- (2008) Leonard G Presta CURRENT OPINION IN IMMUNOLOGY
- Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and Imaging
- (2008) Lily Yang et al. Small
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started